Clinical trials: Lymphedema
Lymphedema
Lymphedema Screening
Breast cancer-related lymphedema is one of the most common and feared consequences of breast cancer treatment. Currently, there is no established screening program for lymphedema.
- Trial name
- LymphScreen (NCT04606511)
- Testing
- Circumference tape measurements, Indocyanine green lymphangiography, bioimpedance spectroscopy
- Where
- Denmark
- Volunteers
- 250 people
- Sponsor
- Odense University Hospital
Lymphedema
Evaluation of Pressure Applying Efficiency in Multi-Layer Bandaging
Lymphedema is a condition characterized by excess accumulation of protein rich tissue fluid in interstitial spaces. It is a progressive chronic disease and without appropriate management may result in serious complications.
- Trial name
- NCT02857621
- Where
- Israel
- Volunteers
- 37 people, healthy volunteers welcome
- Sponsor
- Assuta Hospital Systems
Breast Carcinoma
A Correlational Study: Breast Cancer-related Chest Wall Lymphedema, Quality of Life, and Shoulder Function
This study evaluates how swelling in the chest following breast cancer treatment may affect patients' quality of life and shoulder function.
- Trial name
- NCT06285747
- Testing
- Non-Interventional Study
- Where
- United States
- Volunteers
- 85 people
- Sponsor
- Mayo Clinic
Trachoma, Yaws
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
This is a cluster randomised trial evaluating the safety of co-administering Azithromycin alongside the new IDA (Ivermectin, Diethylcarbamazine, Albendazole) combination treatment for LF.
- Conditions
- Trachoma, Yaws, Lymphatic Filariases, Scabies
- Trial name
- NCT03676140
- Testing
- Albendazole on Day 1, Ivermectin on Day 1, Diethylcarbamazine on day 1
- Where
- Papua New Guinea
- Volunteers
- 20,000 people
- Sponsor
- Lihir Medical Centre
Lymphedema of Genitalia
Exploratory Study : to Evaluate the Panty MOBIDERM in Patients With Pelvic and/or Genital Lymphedema
Lymphedema (LO) is a chronic and disabling condition that affects quality of life. This pathology has a physical, psychological, social and professional impact.
- Trial name
- OLYMPY (NCT04602559)
- Testing
- MOBIDERM Panty group
- Where
- 3 sites in France
- Volunteers
- 32 people
- Sponsor
- Thuasne